Proactive Investors - Run By Investors For Investors

Regency Mines raises £400,0000 for Horse Hill expenditure

The funding news comes a day after the Horse Hill well’s third and final test zone was confirmed as a success.
Regency Mines raises £400,0000 for Horse Hill expenditure
The company agreed a deal to get back into Horse Hill last month.

Regency Mines PLC (LON:RGM)  has announced a £400,000 share placing, priced at 0.6p, with the new funds earmarked for the Horse Hill oil project, near Gatwick airport.

The funding news comes a day after the Horse Hill well’s third and final test zone was confirmed as a success.

Flows from the shallowest part of the well matched the nearby Brockham discovery.

Over a continuous nine hour period, oil from the Portland section of the well flowed at 168 barrels per day, which due to earlier test successes means the aggregate rate for the three test zones exceeded 1,528 bopd.

The company agreed a deal to get back into Horse Hill last month. 

The transaction saw the group acquire a 5% stake in Horse Hill Development Ltd, which in-turn owns 65% of the project.

"Our participation in the Horse Hill project will continue to require funding, and we continue to seek onshore oil projects capable of generating cash flow,” said chairman Andrew Bell.

“Overhead costs have been reduced to a minimal amount as we focus on increasing the value of the company to its shareholders. 

“With the interests of existing shareholders in mind, we are investigating the possibilities of rewarding them either through a bonus issue of warrants or in some other way."

On AIM, Regency Mines shares fell 26% to 0.6p.


View full RGM profile View Profile

Regency Mines Plc Timeline

February 23 2016

Related Articles

drill rig at site
April 10 2018
The company's shares are trading about 8% higher intra-day, at 1.4 cents.
maps of Australia with company projects marked
April 17 2018
Samples from the Mt Read Cobalt Project graded up to 7,800 ppm cobalt.
December 07 2017
King's Bay's drill core is already attracting significant interest, with assays due next month

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use